eagle-i University of Hawaii at ManoaUniversity of Hawaii at Manoa
See it in Search
This page is a preview of the following resource. Continue onto eagle-i search using the button on the right to see the full record.

Standard Risk B-precursor Acute Lymphoblastic Leukemia: A Phase III Groupwide Study

eagle-i ID

http://hawaii.eagle-i.net/i/00000130-b98b-1e53-eee5-4adc80000000

Resource Type

  1. Clinical trial

Properties

  1. ClinicalTrials.gov url
    http://clinicaltrials.gov/show/NCT00103285
  2. Intervention
    Cyclophosphamide
  3. Intervention
    Cytarabine
  4. Intervention
    Dexamethasone
  5. Intervention
    Doxorubicin hydrochloride
  6. Intervention
    Leucovorin calcium
  7. Intervention
    Mercaptopurine
  8. Intervention
    Methotrexate
  9. Intervention
    Pegaspargase
  10. Intervention
    Thioguanine
  11. Intervention
    Vincristine sulfate
  12. Intervention
    Radiation therapy
  13. Additional Name
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
  14. Contact
    Berenberg, Jeffrey
  15. PI
    Wilkinson, Robert, M.D.
  16. Topic
    precursor B lymphoblastic lymphoma/leukemia
  17. Study Population
    Children between 1 and 10 years, with initial white count < 50,000, previously enrolled on COG study # AALL03B1, who are newly diagnosed with B-precursor ALL and have had no prior cytotoxic therapy.
  18. Funded by
    Children's Oncology Group
  19. Phase
    Phase 3 clinical trial
  20. Performed by
    Clinical Protocol & Data Management Shared Resource
 
RDFRDF
 
Provenance Metadata About This Resource Record
Copyright © 2016 by the President and Fellows of Harvard College
The eagle-i Consortium is supported by NIH Grant #5U24RR029825-02 / Copyright 2016